Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to expand seasonal vaccine franchise from three to up to six approved products ...
TAMPA, FL / ACCESS Newswire / November 20, 2025 / (“Wellgistics”) (NASDAQ:WGRX), a health information technology leader at the nexus of serialization of healthcare technology infrastructure into the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback